Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsPrimary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
P2860
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@ast
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@en
type
label
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@ast
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@en
prefLabel
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@ast
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@en
P2093
P2860
P1476
Autologous peripheral blood st ...... h-risk non-Hodgkin's lymphoma.
@en
P2093
Changgong Zhang
Jianliang Yang
Jiarui Yao
Sheng Yang
Shengyu Zhou
Shuxiang Zhang
P2860
P2888
P304
P356
10.1186/S40880-015-0045-3
P577
2015-03-01T00:00:00Z